Pear Therapeutics, Inc. (PEAR)
Upgrades & Downgrades
Latest PEAR news
Why Is Pear Therapeutics (PEAR) Stock Down 26% Today?
14 April 2023
Pear Therapeutics (NASDAQ: PEAR ) stock is falling on Friday after the company's recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics announced its bankruptcy filing while mark...
Why Is Pear Therapeutics (PEAR) Stock Up 21% Today?
21 March 2023
Pear Therapeutics (NASDAQ: PEAR ) stock is climbing higher on Tuesday despite the company's plans to explore strategic alternatives. That news was first announced by the company before markets opened ...
Pear Therapeutics, Inc. (PEAR) Loses -17.39% in 4 Weeks, Here's Why a Trend Reversal May be Around t...
19 January 2023
The heavy selling pressure might have exhausted for Pear Therapeutics, Inc. (PEAR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall St...
Pear Has Captive Markets With reSET, Guides $30 Million In 2023
17 November 2022
Pear is focusing on its established substance abuse products now, putting development on a hold. Performance has been good into onboarding payors that have good coverage in markets where substance abu...
Pear Therapeutics Inc. (PEAR) Q3 2022 Earnings Call Transcript
14 November 2022
Pear Therapeutics Inc. (NASDAQ:PEAR ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Meara Murphy – Senior Director-Corporate Communications Corey McCann – Presiden...
Pear Therapeutics Lays Off 9% Of Workforce, Guides For $15 Million Revenue
18 August 2022
Lots of payors are adding reSET to their covered benefit plans, and savings results far exceed prices of the products, usually leaving about 50% in surplus for the health system. Payor contract econom...
Pear Therapeutics, Inc. (PEAR) CEO Corey McCann on Q2 2022 Results - Earnings Call Transcript
14 August 2022
Pear Therapeutics, Inc. (NASDAQ:PEAR ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Meara Murphy - Senior Director of Corporate Communications Ronan O'Brien - Gener...
Why Earnings Season Could Be Great for Pear Therapeutics (PEAR)
10 August 2022
Pear Therapeutics (PEAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Penny Stocks To Buy Now? 3 With Unusual Options Activity To Watch
24 May 2022
Penny stocks with unusual options activity today. The post Penny Stocks To Buy Now?